Anticancer drugs prices up to 1500% increase. It Antitrust fines Aspen Pharma for 5mio euros

Already in 2014 Altroconsumo filed a complaint to the Antitrust Authority over the consistent price increase – from 250% up to 1.500% - applied to three live-saving anticancer drugs belonging to Aspen Pharma (the so-called Cosmos drugs).
For a certain length of time, those drugs simply disappeared from the market and they became newly available only when their prices were allowed to increased up to 1500%.

The Italian Authority underlines how the abuse of dominant position acted by Aspen Pharma forced AIFA (the Italian Medicinal Agency) to accept the increase of prices, making impossible a real and fair negotiation over the price reimbursements of these drugs (which are paid by the National Health Care System).
In addition to this, the Aspen Pharma strategy of abusing of its dominant position can be considered an infringement of article  102, letter a) of the Treaty on the Functioning of the European Union and, as such, a potential damage for the entire European market.